Literature DB >> 17164568

Prevalence of multiple sclerosis in Bogotá, Colombia.

Jaime Toro1, Olga L Sarmiento, Adriana Díaz del Castillo, Claudia Liliana Satizábal, Jhon Darwin Ramírez, Ana Cristina Montenegro, María Carolina Góngora, Jairo Alonso Quiñones, Andrés Díaz, Alejandro Tobón.   

Abstract

Among Latin American countries, Colombia is considered a low-risk area for multiple sclerosis (MS) and no studies on MS prevalence have been conducted in any of the country's large urban settings. To fill this gap and assess the prevalence of MS in Bogotá as of December 31, 2002, this study reviewed the clinical records of patients diagnosed with MS in most Bogotá hospitals. This review produced a sample of 296 patients with an MS diagnosis whose reliability was verified by a neurologist with expertise in MS. The total prevalence rate identified for December 2002 was 4.41/100,000 inhabitants (95% CI 3.9-4.9), including a rate of 5.98/100,000 (95% CI 5.2-6.8) for women and 2.71/100,000 (95% CI 2.2-3.3) for men (differences measured at p < 0.001). The prevalence estimates for Bogotá, confirm the city's status as a low-risk area for MS.

Entities:  

Mesh:

Year:  2006        PMID: 17164568     DOI: 10.1159/000097854

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  6 in total

1.  Optimizing outcomes in multiple sclerosis: consensus guidelines for the diagnosis and treatment of multiple sclerosis in Latin America.

Authors:  Adriana Carrá; Miguel Ángel Macías-Islas; Alberto Alan Gabbai; Jorge Correale; Carlos Bolaña; Eduardo Duriez Sotelo; Juan García Bonitto; Fernando Vergara-Edwards; Darwin Vizcarra-Escobar
Journal:  Ther Adv Neurol Disord       Date:  2011-11       Impact factor: 6.570

Review 2.  Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases.

Authors:  Glinda S Cooper; Milele L K Bynum; Emily C Somers
Journal:  J Autoimmun       Date:  2009-10-09       Impact factor: 7.094

3.  Increasing incidence of multiple sclerosis among women in Buenos Aires: a 22 year health maintenance organization based study.

Authors:  E Cristiano; L Patrucco; J Miguez; D Giunta; J Peroni; J I Rojas
Journal:  Neurol Sci       Date:  2016-06-23       Impact factor: 3.307

4.  A comparison of linear and nonlinear stability parameters in different clinical forms of multiple sclerosis.

Authors:  Mehrdad Anbarian; Mahnaz Marvi-Esfahani; Mohammad Taghi Karimi; Masoud Etemadifar; Seyed Mohammad Marandi; Mostafa Kamali
Journal:  Eur Rev Aging Phys Act       Date:  2015-11-09       Impact factor: 3.878

5.  Multiple sclerosis epidemiology in Latin America: An updated survey.

Authors:  Edgardo Cristiano; Juan Ignacio Rojas
Journal:  Mult Scler J Exp Transl Clin       Date:  2017-06-13

6.  HLA-DRB1*14 is a protective allele for multiple sclerosis in an admixed Colombian population.

Authors:  Jaime Toro; David Cuellar-Giraldo; Camilo Díaz-Cruz; Lisseth-Estefania Burbano; Claudia-Marcela Guío; Saúl Reyes; Fabián Cortes; Simón Cárdenas-Robledo; Diana M Narváez; Wilmer Cárdenas; Alexandra Porras; María-Claudia Lattig; Helena Groot de Restrepo
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2015-12-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.